Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analysis

Mediterr J Hematol Infect Dis. 2024 May 1;16(1):e2024049. doi: 10.4084/MJHID.2024.049. eCollection 2024.

¹ Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
² Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
³ Division of Hematology and Stem Cell Transplantation, Fondazione Ca'Granda IRCCS Ospedale Maggiore Policlinico, Milan, Italy.
⁴ Department of Hematology, GOM Niguarda Hospital, Milan, Italy.
⁵ Fondazione IRCCS San Gerardo, Monza, Italy.
⁶ Department of Oncology and Hematology, University of Milan, Milano, Italy.

No abstract available

Keywords: Autologous hemopoietic stem cell transplantation; Multiple myeloma; Stem cell mobilization.